Peer Review History
| Original SubmissionFebruary 2, 2022 |
|---|
|
PONE-D-22-03287Genome-wide characterisation of cassava LATERAL ORGAN BOUNDARIES domain genes revealed LBD47 involved in bacterial blight defensePLOS ONE Dear Dr. chen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 11 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Farrukh Azeem Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “This study was supported by the Natural Science Foundation of Hainan Province (320QN193) and the China Agriculture Research System (CARS-11).” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: “This study was financially supported by National Key Research and Development Program (2018YFD1000500) and China Agriculture Research System (CARS-11-hncyh).” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This study was supported by the Natural Science Foundation of Hainan Province (320QN193) and the China Agriculture Research System (CARS-11).” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors reported the AS2/LOB gene family in cassava (Manihot esculenta), in which members contain plant specific AS2/LOB domain. They identified and characterized 55 ASL/LBD genes (MeLBD1 to MeLBD55) from cassava genome using hidden Markov model profiles. They showed that the expression profiles of these genes were highly diverse. Weighted gene co-expression network analysis (WGCNA) of target genes and promoter analysis suggest that some members of cassava MeLBDs may be involved in hormone and stress responses. Furthermore, they described that the promoter analysis suggested that cassava MeLBDs may be involved in the plant phytohormone signal response. Major points: (1) Genome-wide characterisation of the AS2/LOB gene family should be very useful for understanding the function of these genes in cassava. To refine these analysis, they should refer to four papers as following on this subject. Bowman et al., 2017. Insights into Land Plant Evolution Garnered from the Marchantia polymorpha Genome. Cell 171, 287-304 doi.org/10.1016/j.cell.2017.09.030 Machida Y., Suzuki T., Sasabe M., Iwakawa H., Kojima S., Machida C. Arabidopsis ASYMMETRIC LEAVES2 (AS2): roles in plant morphogenesis, cell division, and pathogenesis J. Plant Research 2022 135:3–14 (doi.org/10.1007/s10265-021-01349-6) Coudert, Y.; Dievart, A.; Droc, G.; Gantet, P. ASL/LBD phylogeny suggests that genetic mechanisms of root initiation downstream of auxin are distinct in lycophytes and euphyllophytes. Mol. Biol. Evol. 2013, 30, 569–572. Matsumura Y, Iwakawa H, Machida Y, Machida C (2009) Characterization of genes in the ASYMMETRIC LEAVES2/LATERAL ORGAN BOUNDARIES (AS2/LOB) family in Arabidopsis thaliana, and functional and molecular comparisons between AS2 and other family members. Plant J 58:525–537 According to these papers, LATERAL ORGAN BOUNDARIES domain genes should be written ASYMMETRIC LEAVES2-like/LATERAL ORGAN BOUNDARIES DOMAIN (ASL/LBD) genes, MeLBD should be MeASLBD and the LBD gene family should be the AS2/LOB gene family. In Phylogenetic trees of figure 1, all AtLBD should be written AtASL/LBD, for example, AtASL1/LBD36, AtASL2/LBD10, AtASL3/LBD25, AtASL4/LOB, AtAS2/LBD6, which are classified into Class Ib in this paper. If so, it should be very useful to understand the evolutionary relationship between the ASL/LBD proteins of cassava and those of arabidopsis. In addition, it should be useful for the functionary relationship between them, because the authors can recognize that those with similar numbers are functionally close to each other in arabidopsis. In figure 1, MeLBD should be MeASLBD, for example, MtASLBD1, MtASLBD2, MtASLBD3 like Marchantia (Bowman et al., 2017). (2) AS shown in figure 2, it is very interesting that members of the MeASLBD gene family have one to four exons. Class Ia contain one putative splicing site in the AS2/LOB domain at the same site as that in arabidopsis (see Figure 1b in Matsumura et al., 2009) . In arabidopsis a comparison of the sequences of the cloned cDNAs with those of the corresponding genes revealed that 29 genes contained introns in their coding regions, and these genes could be divided into five subtypes on the basis of the positions of the introns in the coding regions (subtypes A–E). The subtype in arabidopsis seems to be corresponded to subtypes in cassaba. They should describe the relationship of exons/introns in their AS2/LOB domain regions between cassaba and arabidopsis. (3) As shown in Figure 3, multiple sequence alignment of the MeAS2/LOB domain sequences using DNAMAN showed that all sequences contained three subdomeins named C Block, GAS block and L-rich Block. According to the recent two papers as follows, the authors should change the name of subdomain in the AS2/LOB domain. C Block should be written ZF-motif, GAS block should be ICG/GAS-region, L-rich Block should be LZL-region Machida et al., (2022) J. Plant Research 135:3–14 (doi.org/10.1007/s10265-021-01349-6) Chen WF, Wei XB, Rety S, Huang LY, Liu NN, Dou SX, Xi XG (2019) Structural analysis reveals a “molecular calipers” mechanism for a LATERAL ORGAN BOUNDARIES DOMAIN transcription factor protein from wheat. J Biol Chem 294:142–156 (4) The authors described that potential target genes were identified via promoter analysis, and a co-expression network was constructed along with MeLBDs based on a transcriptome dataset derived from pathogen treatment. They found that the MeLBD47 gene expression was highly induced following inoculation with cassava bacterial blight pathogen (XamCHN11), selected for functional analysis. And then the VIGS technique was applied to determine the function of the MeLBD47 gene following XamCHN11 treatment. They described that one thousand four hundred forty genes contain a 5’ GCGGCG 3’ motif in the only promoter of the cassava genome, a putative motif bound by ASL/LBD genes. Although some members of the AS2/LOB family have been shown interaction to 5’ GCGGCG 3’ motif (Husbands et al., 2007; Vial-Pradel et al., 2018; Chen et al., 2018), function of interaction to 5’ GCGGCG 3’ motif is not known yet. Vial-Pradel et al. found that AS2 binds specifically the sequence containing 5’ GCGGCG 3’ motif in exon 1 of ETT/ARF3 (direct target of AS2), and that the binding requires the ZF-motif in AS2 that is structurally similar to the zinc finger-CxxC domain in vertebrate DNA methyltransferase1. In addition, Vial-Pradel et al. showed that AS2 did not bind to DNA sequence containing 5’ GCGGCG 3’ like motif of promoter region of ETT/ARF3. The authors may examine binding to DNA sequence containing 5’ GCGGCG 3’ motif in candidate of target of MeASLBD47 and/or discuss about function of binding to DNA sequence containing 5’ GCGGCG 3’ motif. Vial-Pradel S., Keta S., Nomoto M., Luo L., Takahashi H., Suzuki M., Yokoyama Y., Sasabe M., Kojima S., Tada Y., Machida Y., Machida C. Arabidopsis zinc-finger-like protein ASYMMETRIC LEAVES2 (AS2) and two nucleolar proteins maintain gene body DNA methylation in the leaf polarity gene ETTIN (ARF3). Plant Cell Physiol. 59(7):1385-1397 (2018). (5) In Figure 11b, the authors showed that the leaves of pCsCMV-LBD47 plants were inoculated with XamCHN11, and pCsCMV-LBD47 showed no obvious lesions after three days, although lesions appeared in the pCsCMV-NC (control). They should show quantitative data. (6) Line 349, The authors wrote “Among them, the expressions of HSFC1 HSP90 and GAD1 were significantly downregulated, indicating that they were affected by the effect of VIGS.” However, HSP90 was not downregulated, but upregulated. (7) There is no Figure legends. The authors should write Figure legends for Fig 1-11. (8) In References, The authors did not write name of journal. They should write name of Journal of each reference. (9) Arabidopsis Thaliana should be Arabidopsis thaliana. Reviewer #2: This paper “Genome-wide characterisation of cassava LATERAL ORGAN BOUNDARIES domain genes revealed LBD47 involved in bacterial blight defense” investigates the LBD genes (MeLBD1 to MeLBD55) in cassava genome using hidden Markov model profiles. A lot of papers have been published on cassava plants infected with Xanthomonas axonopodis. The work showed methodological lacks where necessary, unnecessary statements, and weak discussion. The experimental design data has been poorly explored without any statistical analysis and result description. Moreover, the manuscript has a lot of language and editing issues, which should be corrected and needs extensive revision. In some lines, the inappropriate use of English language makes the manuscript really hard to follow. Title: The inappropriate use of English language makes difficult to follow the title. It should be precise and understandable. Abstract: Abstract is not well written, there is no proper background, methods, directly results are discussed without any conclusion. There are lots of English language issues that makes the abstract really hard to follow. Some very basic scientific writing errors are there, such as on line 23 “Arabidopsis Thaliana” is written. It should be written as Arabidopsis thaliana. Keywords: Authors should use full name instead of abbreviation in this part Introduction: The Introduction is poorly written and has many language issues, which need to be corrected. It is advised to get help of English editing service. The literature discussed in one sentence is mostly disconnected from the next sentence, hampering the reading fluency e.g. from Line 43 to 52, 55 to 57, 66 to 67, etc. At some places the meaning of sentence is ambiguous. The information provided need improvement by adding literature relevant to the study conducted. The study objectives are lacking. Authors must clearly present the hypothesis of their study. Methods: The methods description also needs improvements. The authors should use scientific language to write protocols and procedures. More clarity is needed in this section like: • How the Xanthomonas axonopodis infection was given and at which CFU? • How symptoms were monitored post-inoculation and evaluated according to a severity scale? • How the HMM profile was created? • How authors analyzed the conserved domains? • Which model authors used to construct the phylogenetic tree? • What was the optimum width of each motif? • From where authors retrieve the files for analyzing exon-intron structure? • Authors should express the syntenic relationship of the gene pairs and their respective loci in cassava genome. • From where authors retrieve GFF3 file for chromosomal location? • Microcollinearity is valuable to understand the investigation of gene loss during evolution or the evolution of specific genes in a local region. Therefore, authors must do TGT (Triticeae-Gene Tribe) analysis to trace the origin history of the target gene, and also analyze gene pair. Results: Result part need substantial improved. The inappropriate use of English language makes the results hard to follow. For example, from lines 178 to 180, etc. Results are ambiguous. The authors must double check the information given in the manuscript as the methodology section saying something different than what is explained in results section including figures. • The information given in Table 1 is already available on “iTAK - Plant Transcription factor & Protein Kinase Identifier and Classifier”. What new authors have done? • Figures are not clear. Authors must add high resolution figures to make them understandable. Authors must double check whether the information in the figures are same as they have been written in the results section. • There are no figure legends. Authors are advised to add them. • Were the LBD genes groups evenly distributed among chromosomes or different homologous groups? • Methodology and results of synteny analysis are missing while there is heading in the results. • Authors must analyze the duplication event • The results of Exon–intron structure divergences are missing. Authors have only discussed exons but there is no information regarding the introns in all these genes. • The authors must correlate the phylogenetic relationship among LBDs with exon–intron structure • In methodology, authors wrote that “The cassava cultivar used in this study was South China 8 (SC8)” while in the results the authors wrote “The expression profiles of MeLBDs in different tissues (leaves and roots) of the cassava cultivar Argentina 7 (Arg7), wild subspecies (W14) and variety Kasetsart University 50 (KU50) were analysed”. Which information is correct? • What does the heatmap in Figure 6 shows? There is no methodology for this. Results are different from what is said in the methodology. • The results described in “Expression analysis of MeLBD genes in different tissues and organs” are difficult to understand as the figure which is cited in this don’t show the similar information. • There is no methodology for drought. How it appear in the results section? • The transcriptome analysis was done with which treatments and on which plants? • When silencing of MeLBD47 gene was done? What was its methodology? • How the statistical analysis was performed? • What does the stars on the figure 8 show? Discussion: Discussion is very poorly written. This section needs substantial improvement in terms of English language and relevant review of literature. In its current form, it is written much more like introduction and results. In text citation also need revision. Overall, the manuscript seems to be the first rough draft which has to be tidied up in many places and this manuscript in its current form cannot be considered for publication. The manuscript needs extensive revisions before considering it for publication. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Hamid Manzoor [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-03287R1A genome-wide analysis of the ASYMMETRIC LEAVES2-LIKE/LATERAL ORGAN BOUNDARIES (ASL/LBD) gene family in cassava (Manihot esculenta) and expression profile under biotic and abiotic stressPLOS ONE Dear Dr. chen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Farrukh Azeem Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have corrected some of the things I pointed out. However, there are still many shortcomings. In addition, there are many inadequate understandings of important papers published in the past. <comment> Although I suggested four papers to be concerned, the authors did not cite the three papers as follows. They should read precisely, cite them and add them in References. Bowman et al., 2017. Insights into Land Plant Evolution Garnered from the Marchantia polymorpha Genome. Cell 171, 287-304 doi.org/10.1016/j.cell.2017.09.030 Machida Y., Suzuki T., Sasabe M., Iwakawa H., Kojima S., Machida C. Arabidopsis ASYMMETRIC LEAVES2 (AS2): roles in plant morphogenesis, cell division, and pathogenesis. J. Plant Research 2022 135:3–14 (doi.org/10.1007/s10265-021-01349-6) Coudert, Y.; Dievart, A.; Droc, G.; Gantet, P. ASL/LBD phylogeny suggests that genetic mechanisms of root initiation downstream of auxin are distinct in lycophytes and euphyllophytes. Mol. Biol. Evol. 2013, 30, 569–572. <comment> Although I suggested that all AtLBD should be written AtASL/LBD in Figure 1, the authors wrote only 15 genes out of 43 genes as AtASL/LBD. They should change all AtLBD to AtASL/LBD. <comment> Although I pointed, the authors did not change them in Figure 3. They should replace. C Block should be written ZF-motif, GAS block should be ICG/GAS-region, L-rich Block should be LZL-region. <comment> Although the authors described that they could not achieve this analysis due to the timing given, they should understand precisely and cite the following two papers at least. Vial-Pradel S., Keta S., Nomoto M., Luo L., Takahashi H., Suzuki M., Yokoyama Y., Sasabe M., Kojima S., Tada Y., Machida Y., Machida C. Arabidopsis zinc-finger-like protein ASYMMETRIC LEAVES2 (AS2) and two nucleolar proteins maintain gene body DNA methylation in the leaf polarity gene ETTIN (ARF3). Plant Cell Physiol. 59(7):1385-1397 (2018). Chen WF, Wei XB, Rety S, Huang LY, Liu NN, Dou SX, Xi XG (2019) Structural analysis reveals a "molecular calipers" mechanism for a LATERAL ORGAN BOUNDARIES DOMAIN transcription factor protein from wheat. J Biol Chem 294:142–156 <comment> They did not complete to correct yet. They should correct all.</comment></comment></comment></comment></comment> Reviewer #2: I have gone through the revised version of manuscript entitled "A genome-wide analysis of the ASYMMETRIC LEAVES2-LIKE/LATERAL ORGAN BOUNDARIES (ASL/LBD) gene family in cassava (Manihot esculenta) and expression profile under biotic and abiotic stress" (PONE-D-22-03287R1). The authors have made satisfactory changes in the revised version of the manuscript. The manuscript in its current form can be ACCEPTED for publication in PlosONE. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Dr. Hamid Manzoor ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-22-03287R2A genome-wide analysis of the ASYMMETRIC LEAVES2-LIKE/LATERAL ORGAN BOUNDARIES (ASL/LBD) transcription factors (TFs) in cassava ( Manihot esculenta ) and expression profile under biotic and abiotic stressPLOS ONE Dear Dr. chen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 12 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Vibhav Gautam Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #3: (No Response) Reviewer #4: All comments have been addressed Reviewer #5: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #3: No Reviewer #4: Yes Reviewer #5: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have corrected almost all. However, there are still ìnsuffícient part,<comment> All AtLBD should be written AtASL/LBD, for example, AtAS2/LBD6, AtASL1/LBD36, AtASL2/LBD10, AtASL3/LBD25, AtASL4/LOB, AtASL5/LBD12, AtASL6/LBD4, AtASL7/LBD11, AtASL8/LBD1, AtASL9/LBD3, AtASL10/LBD13, AtASL11/LBD15, AtASL12/LBD21, AtASL13/LBD24, AtASL14/LBD23, AtASL15/LBD17, AtASL16/LBD29, and so on. See figure 4 and 5 in Machida et al., 2022 (https://link.springer.com/article/10.1007/s10265-021-01349-6). Nomenclature with ASLs is important. This is because nomenclature with ASLs is based on the amino acid sequence homology of the AS2/LOB domain. Similar amino acid sequences have been shown to be functionally similar. Also in cassava, it will be possible to infer their functions by comparing with ASLs of Arabidopsis thaliana. Two types of nomenclature (ASLs and LBDs in Arabidopsis thaliana) should be listed side by side and such nomenclature with ASLs should be advantageous for discussing relationships between the phylogeny and developmental functions of members in the AS2/LOB protein family. For example, at least four known proteins involved in auxin-induced lateral root formation are named ASL18/LBD16, ASL16/LBD29, ASL20/LBD18, and ASL24/LBD33; ASL15/LBD17 is also proposed to play a similar role. All of them are located in the close clades of sub-class Class Ia of A. thaliana in the phylogenetic tree. During pollen development, ASL1/LBD36, ASL2/LBD10, and ASL3/LBD25, all of which belong to the close narrow clades of the tree, control asymmetric cell division during pollen development. Interestingly, another set of ASL members (SCP/ASL29/LBD27 and ASL30/LBD22 in a small clade) are also involved in the same single process, but at different steps during the progression of pollen development. Note that ASL1/LBD36, ASL2/LBD10, and ASL3/LBD25 belong to Class Ia of A. thaliana, and that SCP/ASL29/LBD27 and ASL30/LBD22 belong to Class Ib of A. thaliana. Use of the ASL nomenclature might provide an edge to discussion of evolutionary developmental biology (evo-devo) of the AS2/LOB family.</comment> Reviewer #3: The manuscript (PONE-D-22-03287) is well-prepared and quite conclusive. The language used in the manuscript is appropriate. The observations have been presented in a proper scientific manner and have been discussed well. Still, there is a scope to uplift the MS, I have a couple of suggestive comments which should further improve the manuscript. Major comments [1] The leaf lesion experiment in the VIGS lines is an important experiment, and currently, the images of the leaves provided are not very convincing. I encourage the authors to provide an image captured under similar light conditions (currently, the brightness and contrast of all the leaf areas are different). Also, Mark the inoculation point with a marker so that the inoculation site and lesion will be visible. Provide a picture of the entire leaf rather than a small section, then zoom in on the necrotic lesion area. [2] Line#367 is there any information about these cultivators' abiotic and biotic stress sensitivity/tolerance? If yes, then provide that will strengthen this motive of the experiment. Minor comments [1] The discussion does not contain the figure references while mentioning the result, and please mention the figure number in the discussion too. [2] Mention the statistical test performed while analyzing the data to test the significance in Figures 5 and 12 [3] Figure 6- Provide an explanation in the legend about the color code provided in the figure. [4] Figure7- Specify tissue type and the variety of cassava used for transcription analysis as mentioned in the figure [5] Figure 8- explain why the MeASLBD19 expression profile is missing (indicated by the gray color) in the disease group. [6] Figure 9- The graph seems confusing; in MeASLBD12 and a few others, the relative expression value is significantly high at six h, but it still shows ns. This needs correction. Mention the statistical test performed. [7] Fig 12b – provide scale bar. Line#42 Gene expression is not a good keyword. Replace it. Line#55, "development of fat symmetric," is this fat or flat? Line#93 what is the basis of dividing into two subclasses? Class II is also divided into subclasses (a-g) which need to be mentioned. Line#151. mentions other cassava cultivars, Arg7, W14, and KU50, that were used for gene analysis. Line#155 Please specify how many leaves were inoculated per plant. Line#156- Write bacterial dilution correctly using the superscript. Line#156-Keep consistency in writing optical density here, it is OD600, while in line#194, it is written as (OD600). Line#157- replace "hole" with "ring" Line#162 - why only two similar replicates were considered? Line#190-192 this explanation is not required, abridged. Line#235 -Provide the hyperlink for the source code and web page for MCscanX. Line#238 -Provide the hyperlink of the source for the Circos software Line#256 provide the source website for the HISAT2 software. Line#378 - RE-frame this sentence as "These results suggest the genotype-dependent tissue expression of these genes." Authors are using genotype and varieties as synonyms which is not the case. For example, in Line#382," cassava cultivars (Arg7 and W14)", these are referred to as Cultivars. However, KU50 and Arg7 are cultivated varieties and W14 wild ancestors. Correct this throughout the MS. Line #382-Why the Variety KU50 not included in the expression analysis under drought treatment studies? Line #385 "had significant differential expression under drought stress." Mention the fold change in expression compared to the control group. Line# 427- "The 347 genes could be divided into four modules via WGCNA" explain the basis of this division into four modules indicated by different colors. Reviewer #4: I found the paper to be well-prepared, with excellent and careful data selection, and it addressed all of the previous reviewers' comments with evidence. This MS could be useful for learning more about how ASYMMETRIC LEAVES2-LIKE/LATERAL ORGAN BOUNDARIES (ASL/LBD) transcription factors (TFs) in plants regulates biotic and abiotic stress responses. Therefore, this MS will timely provide important insight to understand ASL/LBD genes in plants under biotic and abiotic stress responses. However, main concerns associated with the MS are as follows: (I)The authors have corrected most of the things suggested by previous reviewers: 1 and 2. However, I suggest to author please double check the AtLBD. It should be written AtASL/LBD in whole MS including figures and figure legends as also suggested by previous reviewers (twice). (II)The figures and texts of Figure 1, Figure 2, Figure 3, Figure 10, and Figure S1 are unclear. I suggest authors should include high-resolution figures in their work to make it more understandable to a wider audience. Reviewer #5: Mao and Abdoulaye et al - Genome-wide characterization of cassava LATERAL ORGAN BOUNDARIES domain genes revealed LBD47 involved in bacterial blight defense – PLOS ONE The paper builds the study about genome-wide characterization of LBD genes using HMM profiles while establishing the role of MeLBD47 in plant phytohormone signalling in cassava. It showed significantly mitigated virulence of cassava bacterial blight (Xam CHN11) through Virus-induced gene silencing (VIGS). General comment: The manuscript has the topic on the whole well covered and contains interesting set of experiments including VIGS and bioinformatic analyses that can be suitable for publication. Here are my few concerns: Title: Please reframe the title of the paper. It does not sound very conclusive. One suggestion is “Genome-wide analyses of LATERAL ORGAN BOUNDARIES in cassava reveal the role of LBD47 in defense against bacterial blight”. Line 23: ‘T’ small case in Arabidopsis thaliana Line 32: ‘MeLBD47 was selected…’. How was it selected? Randomly? If yes, please mention that and if no, mention what was the basis of its selection for functional analyses? Line 32 and 33: MeLBD47 is italicised somewhere and somewhere not. Please maintain uniformity. Line 65: Add space between esculentaCrantz Line 72: ‘extand’ misspelled Line 99: 2-ΔCT or 2-ΔΔCT ? Line 197-201: Information is repeated from Introduction. Line 283: ‘leaf’, not ‘leave’ Line 343: ‘inoculated with’, not ‘Inoculated’ Discussion: Authors have mentioned in the introduction that this information will provide invaluable insights for further studies. I would suggest that the paper will be more informative if few lines are added in the discussion part about how this information can be put in use and what kinds of further studies can be done. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No Reviewer #4: No Reviewer #5: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Genome-wide analyses of LATERAL ORGAN BOUNDARIES in cassava reveal the role of LBD47 in defence against bacterial blight PONE-D-22-03287R3 Dear Dr. chen, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Vibhav Gautam Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-03287R3 Genome-wide analyses of LATERAL ORGAN BOUNDARIES in cassava reveal the role of LBD47 in defence against bacterial blight Dear Dr. Chen: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Vibhav Gautam Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .